Neos Therapeutics Is Hitting A Considerable Air Pocket

  • Neos is buffeted by the pandemic and wholesaler inventory levels which have produced declines in subscriptions and revenues.
  • The full impact of the pandemic has yet to be felt as Q2 will be considerably worse.
  • The company embarked on cost cutting, but for the shares to recover, sales need to grow well above their pre-pandemic levels, which is far from a given.

Source: Neos Therapeutics Is Hitting A Considerable Air Pocket (NASDAQ:NEOS) | Seeking Alpha